Clinical Study "Common" Name (formal title)	Number of enrollees	Funding source (pharmaceutical company/National Institutes of Health [NIH])	Year complete	Primary publication	Full study treatment protocol/patient disposition
VISTA/VIVID (Study of Intravitreal Aflibercept Injection [IAI; EYLEA; BAY86-5321] in Patients With Diabetic Macular Edema [VISTA DME]) Intravitreal Aflibercept Injection in Vision Impairment Due to DME (VIVID-DME)	VISTA: 466 VIVID: 406	VISTA: NCT01363440 VIVID: NCT01331681	VISTA: 2014 VIVID: 2015	Korobelnik JF, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247-54. https://www.aaojournal.org/article/S0161-6420(14)00426-6/fulltext